February 19, 2026
A computer-based cognitive training program focused on speed of processing — reinforced with periodic booster sessions — reduced the risk for Alzheimer’s disease and related dementias […]
February 19, 2026
TOKYO, Feb 19 (Reuters) – Japan’s health ministry said on Thursday a panel of specialists had endorsed Sumitomo Pharma’s iPS cell-derived treatment for Parkinson’s disease, paving […]
February 18, 2026
SAN DIEGO — Results from two phase 3 trials offer mixed findings on the potential of experimental Bruton tyrosine kinase (BTK) inhibitors for primary progressive multiple […]
February 18, 2026
TOPLINE: In real-world clinical practice, adding p‑tau217 testing significantly improved diagnostic accuracy and increased neurologists’ diagnostic confidence, with marked reclassification seen in mild cognitive impairment and […]
February 17, 2026
Advanced chronic traumatic encephalopathy (CTE) is associated with a fourfold increased risk of dementia and is often misdiagnosed as Alzheimer’s disease (AD). Results of a large […]
February 16, 2026
SAN DIEGO — Treatment with daratumumab, a monoclonal antibody approved to treat multiple myeloma, was associated with a significant decrease in relapse risk in patients with […]
February 16, 2026
Sleep disorders affect an estimated 50-70 million Americans and are linked to cardiovascular disease, cognitive impairment, metabolic dysfunction, and increased accident risk. Yet despite established therapies […]
February 16, 2026
Adherence to a Mediterranean diet was associated with lower risk for total stroke as well as ischemic and hemorrhagic stroke among women. In a prospective cohort […]
February 13, 2026
Growing evidence suggests that orgasm is not solely dependent on genital stimulation but involves complex central nervous system mechanisms. As psychologist and sexologist Ana Lombardía explained […]